baber/WOPTO huggingface dataset:
Patent CA-2498647-A1 (CA)
Title: Pallet for hand truck
Inventor: VANDEKEMP HARRY
IPC: B65D19/24
Filed: 2005-03-17
Abstract: This is a pallet to be used for relocating and storing goods. It is made mobile with the aid of a standard hard truck The overall dimensions of the pallet are 20 inches wide, by 11 inches deep, by 6 inches high. There is a slot on the bottom of the pallet for a plate of a standard hand truck to be inserted. The pallet can then be relocated while on the hand truck.
Patent CA-2503354-A1 (CA)
Title: System and method for providing selection diversity for multicasting content
Inventor: RANTA-AHO KARRI
IPC: H04L12/56
Filed: 2003-10-27
Abstract: The invention provides a method and system for providing multicasting conten t in a network having several cells which can communicate with one or more terminals such as user equipments, the terminals being able to select which cell or cells they desire to communicate which, wherein at least some of the cells transmitting multicasting content also transmit cell information on on e or more other cells transmitting the same multicasting content, the terminal or terminals selecting one of the cells transmitting multicasting content which the terminal intends to receive, based on this information.
Patent CA-2503824-A1 (CA)
Inventor: JACKSON JEFFERY N
IPC: B29C55/16
Filed: 2003-10-21
Abstract: Des films polymères étirés peuvent être utilisés dans une variété d'applications, y compris des applications optiques. Les conditions d'étirement et la forme des voies d'étirement (64) dans un appareil d'étirement peuvent déterminer ou influencer les propriétés des films. Des systèmes de tirage (140, 140', 141, 141' ) peuvent être utilisés afin de recevoir le film après étirement. La configuration du système de tirage peut, au moins dans certains cas, influencer les propriétés finales de films.
Patent CA-2505141-A1 (CA)
Inventor: HILL GEOFFREY R
IPC: A61K38/17
Filed: 2003-11-06
Abstract: The invention is directed to the use of cpn10 in transplantation and particularly to treatment and/or prevention of graft versus host disease. Th e invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, althoug h in a particularly advantageous form treatment of both the donor and recipien t animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease.
Patent CA-2506083-A1 (CA)
Title: Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonane compounds and method of treatments relating to arrhythminc events
Inventor: CAUTREELS WERNER
IPC: A61P9/06
Filed: 2003-11-17
Abstract: The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7~diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or prophylaxis of anti-arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation (Afib) or flutter to normal sinus rhythm (NSR) in human patients. Furthermore, the invention relates to method of treatments and to pharmaceutical products.
Patent CA-2509008-A1 (CA)
Inventor: DINGLE PAMELA
IPC: G06F9/44
Filed: 2005-06-02
Abstract: The invention provides for transferring program elements; such as objects, attributes, data and applications; from a source environment to a receiving environment using an Object Transformer, Environment Configurator, Object Selector, and Object Migrator to identify and implement environment and program element specific relationships in a receiving environment based on current relationships in the source environment and historical transfers to the receiving environment.
Patent CA-2509391-A1 (CA)
Title: Fault characterization using information indicative of echo
Inventor: RUDE MICHAEL J
IPC: H04M1/24
Filed: 2003-12-12
Abstract: A fault associated with a communication medium (134) is analyzed by correlating a first set of information indicative of echo associated with the communication medium (134) with a second set of information indicative of echo. The fault is characterized based on the correlation between the first set of information and the second set of information. The first set of information and the second set of information can include echo canceller coefficients generated by an echo canceller (142) coupled to the communication medium (134).
Patent CA-2510363-A1 (CA)
Title: Portable folding field stand for holding paintball markers
Inventor: MACDONALD JOHN C
IPC: B60R7/14
Filed: 2005-06-21
Abstract: A portable folding field stand for supporting multiple fully assembled paintball markers by their barrels and air tanks in a horizontal, upright position; consisting of a rectangular base section; a barrel support bulkhead; and a tank support bulkhead. The base section is hingedly attached along one edge to the barrel support bulkhead edge and along an opposing edge to the tank support bulkhead. The tank support bulkhead has uniformly spaced tank support yokes, and the barrel support bulkhead has corresponding barrel support yokes. The bulkheads are foldable on the base section between two positions, open for use and closed for transport or storage. Both bulkheads have L shaped profiles that extend the available underside area of support when open and provide a suitcase-like profile to the stand when closed. The barrel support yokes are individually vertically adjustable to accommodate different markers.
Patent CA-2511484-A1 (CA)
Title: Silk-containing stent graft
Inventor: TOLEIKIS PHILIP M
IPC: A61F2/06
Filed: 2003-12-29
Abstract: Silk-containing stent grafts are provided comprising an endoluminal stent an d a graft, wherein the silk is induces the in vivo adhesion of the stent graft to vessel walls, or, otherwise induces or accelerates an in vivo fibrotic reaction causing said stent graft to adhere to vessel wall. Also provided ar e methods for making and using such stent grafts.
Patent CA-2513292-A1 (CA)
Inventor: TSUI BO YIN
IPC: C12Q1/68
Filed: 2004-01-16
Abstract: Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclampsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.
Patent CA-2514875-A1 (CA)
Title: Rapid absorption selective 5-ht agonist formulations
Inventor: MAES PAUL
IPC: A61K9/20
Filed: 2004-02-18
Abstract: The invention provides for a rapid absorption pharmaceutical composition comprising an effective amount of at least one selective 5-HT agonist, at least one spheronization aid and at least one solubility enhancer. The composition of the invention is incorporated into microparticles, which may be subsequently taste-masked and incorporated into a variety of dosage forms for administration to a patient suffering from migraine.
Patent CA-2516070-A1 (CA)
Title: Laser gated camera imaging system and method
Inventor: INBAR SHAMIR
IPC: G01S7/486
Filed: 2004-02-04
Abstract: A gated camera imaging system and method, utilizing a laser device for generating a beam of long duration laser pulses toward a target. A camera receives the energy of light reflexes of the pulses reflected from the target.  The camera gating is synchronized to be set OFF for at least the duration of time it takes the laser device to produce a laser pulse in its substantial entirety, including an end of the laser pulse, in addition to the time it takes the laser pulse to complete traversing a zone proximate to the system and back to the camera, and set ON for an ON time duration thereafter until the laser pulse reflects back from the target and is received in the camera.  The laser pulse width substantially corresponds to at least the ON time duration. Preferably, the laser device includes a Diode Laser Array (DLA).
Patent CA-2519436-A1 (CA)
Inventor: ZANK GUNNAR
IPC: H04L12/413
Filed: 2004-03-25
Abstract: Disclosed is a system for installing withdrawable units (11) into switchgears.  Said withdrawable units (11) are installed on certain levels (12, 14, 16, 18) of switchgear cabinets (10), communicate via a fieldbus, and are unambiguously identified via a unit address while basic data required for operating the unit is contained in a memory of the withdrawable unit. Each switchgear cabinet (10) is provided with at least one Ethernet switch (20) with which at least the withdrawable units communicate. An application server (30) managing at least the TCP/IP address allocation as well as a database (40) in which at least the unit data of at least the withdrawable units (11) is at least stored and/or managed are also part of the system. Further disclosed is a method for installing withdrawable units (11) into switchgears, said withdrawable units (11) being installed on certain levels (12, 13, 16, 18) of a switchgear cabinet (10), communicating via a fieldbus, being unambiguously identifiable via a unit address, and containing, in a memory, basic data required for operating the unit. Communication via the fieldbus is based on Ethernet TCP/IP  technology, the unit addresses of the withdrawable units (11) are automatically assigned thereto and managed by an application server (30) which is integrated into the Ethernet network, and at least the basic data for each withdrawable unit (11) is automatically downloaded from a database (40) into the withdrawable unit (11).
Patent CA-2525554-A1 (CA)
Inventor: PROSISE ROBERT LAWRENCE
IPC: A61F13/20
Filed: 2004-05-12
Abstract: A process and apparatus for producing stabilized compressed tampons are disclosed. The process includes the steps of providing a compressed tampon pledget and forcing gas through the compressed tampon. In some embodiments, the process may occur in the presence of moisture. The moisture can come from either the fibers of the material that comprises the tampon pledget and/or from the humidified gas or steam that is introduced. The process may include the steps of heating and/or humidifying the gas introduced during the process.  The gas may be forced through the compressed tampon pledget intermittently during the process.
Patent CA-2527997-A1 (CA)
Inventor: IFTIME GABRIEL
IPC: G09F9/35
Filed: 2005-11-25
Abstract: A cholesteric display including a liquid crystalline mixture having a dipolar dopant dissolved in the liquid crystalline mixture and the resulting mixture is reflecting light in the visible range of the spectrum when in planar state. In accordance with another aspect, a process includes forming a composition with a dipolar molecule to result in a liquid crystal dipolar dopant, and liquid crystal is added to the composition. In accordance with still another aspect, a device includes a liquid crystal composition includes a cholesteric liquid and a dipolar dopant. The liquid crystal composition is switchable between a focal-conic state and a planar state in the presence of an electric field and is stable in the respective state when the electric field is removed.
Patent CA-2529000-A1 (CA)
Inventor: HECHMATI LAURENT
IPC: B65D25/20
Filed: 2004-05-28
Abstract: A foldable air insulating sleeve (20) for insulating beverage and food containers. The sleeve (20) secures a cup (60) in a manner that leaves a pocket of air (68) surrounding the cup. This provides for improved temperature regulation and sufficient thermal insulation to assist the user in firmly grasping and handling the cup despite excess heat or condensation caused by the temperature of the cup's contents. A lid (108) further improves thermal insulation.
Patent CA-2530263-A1 (CA)
Inventor: JOHANSEN ELIZABETH WHITNEY
IPC: A61M5/315
Filed: 2004-08-09
Abstract: A medication dispensing apparatus that provides a mechanical advantage. Duri ng dose preparing, a nut rotating element (410) and a screw element (368) are i n a first axial arrangement such that a screwing motion of the nut rotating element and screw element relative to the apparatus housing that moves the elements a first axial distance from a home position screws a nut (364) alon g a drive member threaded shaft (362) a second axial distance different than t he first axial distance. During dose dispensing, the nut rotating element and t he screw element are in a second axial arrangement, whereby a screwing motion o f the screw element relative to the housing back toward the home position advances a plunger (366) in the distal direction to axially advance the nut and thereby the drive member and a fluid container piston to dispense medici ne.
Patent CA-2530680-A1 (CA)
Inventor: NYGAARD ANNE-METTE
IPC: C07J3/00
Filed: 2004-04-02
Abstract: A method for the conversion of steroidal 17.beta.-carboxylic acids to c carbothioic acid and esters thereof such as fluticasone propionate.
Patent CA-2533497-A1 (CA)
Title: Pdc drill bit using optimized side rake angle
Inventor: HUANG SUJIAN J
IPC: E21B10/54
Filed: 2006-01-20
Abstract: The invention relates to fixed cutter drill bits used to drill boreholes in subterranean formations. The invention provides for a drill bit comprising cutters positioned along a blade of the drill bit in a cone region and cutters positioned along the blade in a nose region, wherein the cutters in the cone region toward a center of the drill bit have larger side rake angles than the cutters positioned along the nose region.
Patent CA-2534458-A1 (CA)
Title: 8-chloro-2,3-benzodiazepine derivatives
Inventor: BARKOCZY JOZSEF
IPC: C07D243/02
Filed: 2004-07-29
Abstract: The invention relates to new 8-chloro-2,3-benzodiazepine derivatives of the general formula (I),wherein R stands for a lower alkyl group or a group of the general formula -NH-R', wherein R' stands for a lower alkyl or a lower cycloalkyl group), and pharmaceutically acceptable acid addition salts thereof. The invention also encompasses a process for the preparation of said compounds, pharmaceutical compositions containing them and new intermediates useful for the preparation of the new 8-chloro-2,3-benzodiazepine derivatives.The compounds according to the invention possess AMPA/kainate receptor inhibiting activity.
Patent CA-2534637-A1 (CA)
Title: Methods and apparatus for routing of information depending on the traffic direction
Inventor: GUICHARD JAMES N
IPC: H04L12/56
Filed: 2004-09-29
Abstract: In a network supporting virtual private network (VPN) connections, a first network node (132) maintains separate routing policy information (130) to forward network traffic depending on a direction of the network traffic.  Upstream routing policy information (130-1) at the first node identifies a second node (134) to forward upstream traffic received from at least a first client (110-1) communicating through the first node. Downstream routing policy information (130-2) at the first node identifies how to forward downstream network traffic received from another node to the first client. By preventing use of the downstream policy routing information by the first client to route upstream network traffic, the first node is able to forward traffic along a path that the network traffic otherwise would have not traveled. For example, network traffic communicated through the first node can be forced to travel through another network node through which it would have not otherwise have passed if the downstream policy information was available to route the network traffic.
Patent CA-2537523-A1 (CA)
Title: Contenant distributeur
Inventor: ELLIOTT HOWARD
IPC: B65D75/36
Filed: 2003-09-09
Abstract: L'invention concerne un contenant permettant de stocker et de distribuer des produits de grande consommation et pouvant remplacer les emballages-coques classiques destinés au conditionnement des pilules, comprimés ou capsules ou les contenants multi-cavité destinés à organiser et stocker une médication mixte pour la distribution consécutive selon un régime de dosage prédéfini. Ce contenant comprend un plateau (1) ayant une surface supérieure (2) généralement plane dans laquelle est formée au moins une cavité discrète (3) permettant de recevoir les produits de grande consommation. Une feuille (10) est collée à la surface supérieure (2) du plateau (1) à l'aide d'un adhésif pelable permettant de sceller la ou les cavité(s) (3). La feuille (10) a des lignes de pointillés (13) préformées définissant, par cavité (3), une section détachable (12) permettant de retenir les produits de grande consommation dans cette cavité jusqu'à son détachement par rupture le long de ses lignes de pointillés. La ou chaque section détachable (12) a des propriétés de faible transmission de vapeur obtenues par une pièce (24) aux propriétés barrière de vapeur élevées.
Patent CA-2540360-A1 (CA)
Title: Process for the preparation of risperidone
Inventor: KULKARNI ASHOK KRISHNA
IPC: C07D471/04
Filed: 2004-09-24
Abstract: A process is provided for the preparation of risperidone of Formula (1); which process comprises reacting, in a condensation reaction, 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole monohydrochloride of Formula (2) with 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,a]pyrimidin-4-one monohydrochloride of Formula (3).
Patent CA-2541665-A1 (CA)
Inventor: ASBAHR HARK-OLUF
IPC: C10L1/08
Filed: 2006-04-03
Abstract: The invention relates to a method of increasing the oxidation stability of biodiesel, which comprises adding at least one primary antioxidant having the structure (see formula I, II) where (see formula III), -S-, n = 1 to 5, E = methyl, tert-butyl, (see formula IV or V) R1, R4, R5 = hydrogen, an alkyl group, and R2 = hydrogen, a methyl group, to the biodiesel to be stabilized in an amount of from 10 to 20 000 ppm (w/w), the use of these primary antioxidants for increasing the oxidation stability of biodiesel and also the corresponding oxidation-stabilized biodiesel.
Patent CA-2541792-A1 (CA)
Title: Injection molding nozzle with two discharge openings
Inventor: SPULLER SWEN
IPC: B29C45/23
Filed: 2006-04-05
Abstract: An injection molding nozzle with a discharge opening 1 and a positively controlled closure element 2, by which a communication opening of an injection mold can be closed, is characterized in that short stroke means 3 are provided by which the closure element 2 is movable by a short stroke in the direction opposite to the closing direction 6 of the closure element 2.
Patent CA-2543396-A1 (CA)
Inventor: MOORE THOMAS M
IPC: G01N23/22
Filed: 2004-06-08
Abstract: We disclose a method for analyzing the composition of a microscopic particle (100) resting on a first sample surface (110). The method comprises positioning a micro-manipulator probe (120) near the particle (100); attaching the particle (100) to the probe (120); moving the probe (120) and the attached particle (100) away from the first sample surface (110); positioning the particle (100) on a second sample surface (150); and, analyzing the composition of the particle (100) on the second sample surface (150) by energy-dispersive X-ray analysis or detection of Auger electrons. The second surface (150) has a reduced or non-interfering background signal during analysis relative to the background signal of the first surface (110). We also disclose methods for adjusting the electrostatic forces and DC potentials between the probe (120), the particle (100), and the sample surfaces (110, 150) to effect removal of the particle (100), and its transfer and relocation to the second sample surface (150).
Patent CA-2544612-A1 (CA)
Inventor: CHEVALLET JACQUES
IPC: A61M1/16
Filed: 2004-11-02
Abstract: A degassing device (203) comprises a first chamber (21) having an inlet for a liquid, and a second chamber (22) having an opening (23) closed by a hydrophobic membrane (24) and an outlet (25) for discharging the liquid. The first chamber (21) has a downstream portion that partially extends within the second chamber (22) and communicates therewith by a passageway (28). The second chamber (22) has a downstream portion that extends below the passageway (28) and asymmetrically surrounds the downstream portion of the first chamber (21).
Patent CA-2544902-A1 (CA)
Title: A process for isolating, purifying and formulating a stable, commercial grade lutein paste from oleoresin
Inventor: BHASKARAN SUNIL
IPC: C07C35/08
Filed: 2005-01-17
Abstract: The present invention relates to a process for obtaining stabilized Lutein with about 95% yield from oleoresin at ambient temperature, said process comprising steps of dissolving cleaned oleoresin in alcohol to obtain dissolved Xanthophylls esters as clear solution on filtration, cleaning dissolved oleoresin comprising xanthophylls esters in ion-exchange resin, hydrolyzing the clear solution with base in presence of phase-transfer catalyst in alcohol medium, quenching the hydrolyzed solution in water maintaining acidic pH to obtain un-dissolved solids on filtration, dissolving the solids in ester to obtain ester layer on filtration, drying ester layer to obtain semi-solid residue, triturating the semi-solid residue in alcohol whereby obtaining lutein crystals of about 65% assay and an alcoholic fraction, distilling the alcoholic fraction to obtain non water-soluble fractions, and mixing the Lutein crystals with non water-soluble fractions to obtain a stable Lutein paste.
Patent CA-2547326-A1 (CA)
Inventor: SHARMA MRIDULA
IPC: C07H21/04
Filed: 2004-11-26
Abstract: The present invention provides for a novel muscle growth regulating factor, including polynucleotide and polypeptide sequences, promoter sequences, constructs comprising the sequences, and compositions for regulating muscle growth and treating diseases associated with muscle growth. The present invention also provides to the use of the present sequences in identifying animals with altered muscle mass, and for selective breeding programmes to produce animals with altered muscle mass.
Patent CA-2548100-A1 (CA)
Title: Methods and compositions for treatment of interferon-resistant tumors
Inventor: BENEDICT WILLIAM F
IPC: A61K38/21
Filed: 2004-12-10
Abstract: The present invention provides a method for the treatment of interferon resistant tumors through the use of recombinant vectors encoding interferon species. In particular it is noted that interferon species provided by recombinant vectors possesses properties not associated with the recombinantly produced interferon proteins. The present invention further provides compositions useful in the treatment of interferon resistant tumors using recombinant vectors encoding interferons.